The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
NCT ID: NCT01310062
Last Updated: 2011-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1600 participants
OBSERVATIONAL
2010-08-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
NCT02148562
Biologic Basis of Liver Cancer From Chronic Hepatitis B
NCT03300414
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
NCT00767936
A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB
NCT05057065
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
NCT02366286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be able and wiling to give an informed consent
* Patient with chronic HBV infection
* Patient with active hepatocellular carcinoma and chronic hepatitis B
* Healthy subjects
Exclusion Criteria
* Subjects with other types of cancer
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GeneNews Sdn Bhd
UNKNOWN
Ministry of Health, Malaysia
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GeneNews Sdn Bhd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sultanah Bahiyah Hospital
Alor Star, Kedah, Malaysia
Kuala Lumpur Hospital
Kuala Lumpur, Kuala Lumpur, Malaysia
Island Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Lam Wah Ee Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Penang Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Queen Elizabeth Hospital
Kota Kinabalu, Sabah, Malaysia
Hospital Umum Kuching Sarawak
Kuching, Sarawak, Malaysia
Selayang Hospital
Selayang Baru Utara, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-317-3991
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.